Antonio Madejón
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
Papers in
- Hepatology 22
- Hepatitis C virus research 21
- Hepatitis Viruses Studies and Epidemiology 2
- Epidemiology 20
- Hepatitis B Virus Studies 18
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Vincent Soriano (14 shared papers)Javier García‐Samaniego (18 shared papers)Javier Bartolomé (8 shared papers)Eugenia Vispo (7 shared papers)Inmaculada Castillo (6 shared papers)Pablo Barreiro (7 shared papers)Marcelle Bottecchia (6 shared papers)Pablo Labarga (7 shared papers)
- Journals
- Journal of Hepatology (8 papers)Journal of Antimicrobial Chemotherapy (2 papers)The Journal of Infectious Diseases (2 papers)Journal of Viral Hepatitis (2 papers)Antiviral Therapy (2 papers)
- Partner nations
- SpainUnited KingdomNetherlands
In The Last Decade
Antonio Madejón
41 papers receiving 1.1k citations
Antonio Madejón's Hit Papers
Peers
Comparison fields: 5 of 60
- Hepatology 530
- Pharmacology 183
- Epidemiology 312
- Infectious Diseases 87
- Virology 12
Countries citing papers authored by Antonio Madejón
This map shows the geographic impact of Antonio Madejón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Madejón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Madejón more than expected).
Fields of papers citing papers by Antonio Madejón
This network shows the impact of papers produced by Antonio Madejón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Madejón. The network helps show where Antonio Madejón may publish in the future.
Co-authors
The 25 scholars most cited alongside Antonio Madejón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry Hit paper breakdown → | 2021 | 116 |
| 2 | 2018 | 88 | |
| 3 | 2014 | 73 | |
| 4 | 2018 | 60 | |
| 5 | 1994 | 58 | |
| 6 | 1997 | 53 | |
| 7 | 2013 | 52 | |
| 8 | 2020 | 52 | |
| 9 | 2009 | 50 | |
| 10 | 2008 | 39 | |
| 11 | 2010 | 37 | |
| 12 | 2021 | 37 | |
| 13 | 2019 | 36 | |
| 14 | 2009 | 33 | |
| 15 | 2010 | 32 | |
| 16 | 2010 | 30 | |
| 17 | 2010 | 29 | |
| 18 | 2013 | 27 | |
| 19 | 1995 | 26 | |
| 20 | 1990 | 23 |
About Antonio Madejón
Antonio Madejón is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Pharmacology and Nuclear Energy and Engineering, having authored 43 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (21 papers), Hepatitis B Virus Studies (18 papers), COVID-19 Clinical Research Studies (3 papers), Hepatitis Viruses Studies and Epidemiology (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), HIV/AIDS Research and Interventions (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Hepatology (530 citations), Pharmacology (183 citations), Epidemiology (312 citations), Infectious Diseases (87 citations) and Virology (12 citations). Antonio Madejón has collaborated with scholars based in Spain, United Kingdom and Netherlands. Frequent co-authors include Vincent Soriano, Javier García‐Samaniego, Javier Bartolomé, Eugenia Vispo, Inmaculada Castillo, Pablo Barreiro, Marcelle Bottecchia, Pablo Labarga, Paula Tuma and J. Medraño. Their work appears in journals such as Journal of Hepatology, Journal of Antimicrobial Chemotherapy, The Journal of Infectious Diseases, Journal of Viral Hepatitis and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.